Message from Schizophrenia Alliance, Coordinator Katie L.

In these eventful times, it may be good to take a moment, for ourselves. Perhaps, leaving Facebook and Twitter to fend for themselves; and to focus on our coping skills. What coping skills are we using to help bring ourselves to the surface? Are we acquainted with the calm place inside of us? Have youRead More

[Continue reading…]

Message from FFS, Family and Friends, Coordinator Mary Ross

Ideally ‘self-care’ should be at the top of our priorities in our lives. We love our family members, our friends, but if we are not at our optimal best we are less able to be there in a support role of them. In my search for self-care I realized that I fortunately have found myselfRead More

[Continue reading…]

Message From Executive Director

Dear Friends, Thank you all for the courageous and brave work you do every day. Everyone who lives with psychosis and wakes up to live each day to their best ability and maintain their plan to pursue a meaningful day, congratulations. Everyone who helps their loved one or others get through each day inRead More

[Continue reading…]

Strategies to Improve Mental Health Care for Children and Adolescents: Research Review

The Agency for Healthcare Research and Quality review assesses the effectiveness of quality improvement, implementation, and dissemination strategies that seek to improve the mental health care of children and adolescents. Approximately one in five children and adolescents living in the United States has one or more mental, emotional, or behavioral health disorders according to theRead More

[Continue reading…]

HHS selects eight states for new demonstration program to improve access to high quality behavioral health services

HHS announced the selection of eight states for participation in a two-year Certified Community Behavioral Health Clinic (CCBHC) demonstration program designed to improve behavioral health services in their communities. This demonstration is part of a comprehensive effort to integrate behavioral health with physical health care, increase consistent use of evidence-based practices, and improve access toRead More

[Continue reading…]

Chantix and Zyban: Drug Safety Communication – Mental Health Side Effects Revised, FDA

Based on a Food and Drug Administration (FDA) review of a large clinical trial that FDA required the drug companies to conduct, FDA determined the risk of serious side effects on mood, behavior, or thinking with the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) is lower than previously suspected. The risk of these mental healthRead More

[Continue reading…]

Adding Better Mental Health Care to Primary Care

Many people visit a primary health care provider to treat physical diseases and injuries; however, it is also common for patients to see a primary care provider because of brain health issues, including such as depression, anxiety, alcohol use and might be the first contact for schizophrenia prodrome. The primary care provider can treat someRead More

[Continue reading…]

SERIOUS MENTAL ILLNESS AMONG ADULTS BELOW THE POVERTY LINE

The challenges that adults with mental illness face are made more difficult if they are living in poverty. For example, adults with mental illness who are living in poverty may face higher health care costs, decreased productivity, and poor general health. According to the National Survey of Drug Use and Health (NSDUH), an estimated 9.8 million adultsRead More

[Continue reading…]

As Some States Implement New Marijuana Laws, Science Should Guide Public Health Policy

After the election on November 8, marijuana is now or will soon be legal for adult recreational use in eight states plus the District of Columbia. These states, and those that may join them in the future, will have choices to make in how they enact and implement their policies. Careful thought should be givenRead More

[Continue reading…]

Metabolic Changes in Schizophrenia May Predate Antipsychotic Use

By the time a person with schizophrenia presents at the onset of the illness, he or she may already be experiencing glucose dysregulation—increasing the risk of type 2 diabetes, a meta-analysis published today in JAMA Psychiatry reports. The findings highlight the importance of prescribing antipsychotics at a dose that limits the metabolic impact and educatingRead More

[Continue reading…]